These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 33355171)

  • 1. Proton beam irradiation of uveal melanoma involving the iris, ciliary body and anterior choroid without surgical localisation (light field).
    Oxenreiter MM; Lane AM; Aronow MB; Shih H; Trofimov AV; Kim IK; Gragoudas ES
    Br J Ophthalmol; 2022 Apr; 106(4):518-521. PubMed ID: 33355171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conservative management of suspicious melanocytic lesions of the iris.
    Oxenreiter MM; Lane AM; Jain P; Kim IK; Gragoudas ES
    Graefes Arch Clin Exp Ophthalmol; 2019 Jun; 257(6):1319-1324. PubMed ID: 30919077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uveal tumour resection.
    Char DH; Miller T; Crawford JB
    Br J Ophthalmol; 2001 Oct; 85(10):1213-9. PubMed ID: 11567967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ruthenium plaque radiation therapy for iris and iridociliary melanomas.
    Razzaq L; Keunen JE; Schalij-Delfos NE; Creutzberg CL; Ketelaars M; de Keizer RJ
    Acta Ophthalmol; 2012 May; 90(3):291-6. PubMed ID: 20670343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal bevacizumab for neovascular glaucoma in uveal melanoma treated by proton beam therapy.
    Mahdjoubi A; Najean M; Lemaitre S; Dureau S; Dendale R; Levy C; Rouic LL; Desjardins L; Cassoux N
    Graefes Arch Clin Exp Ophthalmol; 2018 Feb; 256(2):411-420. PubMed ID: 29116399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plaque radiation therapy for malignant melanoma of the iris and ciliary body.
    Finger PT
    Am J Ophthalmol; 2001 Sep; 132(3):328-35. PubMed ID: 11530044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant Ab Interno Tumor Treatment After Proton Beam Irradiation.
    Seibel I; Riechardt AI; Heufelder J; Cordini D; Joussen AM
    Am J Ophthalmol; 2017 Jun; 178():94-100. PubMed ID: 28365241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for neovascular glaucoma after proton beam therapy of uveal melanoma: a detailed analysis of tumor and dose-volume parameters.
    Mishra KK; Daftari IK; Weinberg V; Cole T; Quivey JM; Castro JR; Phillips TL; Char DH
    Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):330-6. PubMed ID: 23886415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neovascular glaucoma after proton beam therapy of choroidal melanoma: incidence and risk factors.
    Riechardt AI; Pilger D; Cordini D; Seibel I; Gundlach E; Hager A; Joussen AM
    Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2263-2269. PubMed ID: 28721444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraocular collision tumour: case report and literature review.
    Coupland SE; Dodson A; Liu H; Du MQ; Angi M; Damato BE
    Graefes Arch Clin Exp Ophthalmol; 2013 May; 251(5):1383-8. PubMed ID: 23232651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrence of iris melanoma after proton beam therapy.
    Sandinha MT; Kacperek A; Errington RD; Coupland SE; Damato B
    Br J Ophthalmol; 2014 Apr; 98(4):484-7. PubMed ID: 24414401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton Therapy for 166 Patients with Iris Melanoma: Side Effects and Oncologic Outcomes.
    Gollrad J; Böker A; Vitzthum S; Besserer A; Heufelder J; Gauger U; Böhmer D; Budach V; Zeitz O; Joussen AM
    Ophthalmol Retina; 2023 Mar; 7(3):266-274. PubMed ID: 36087876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasonography and transillumination for uveal melanoma localisation in proton beam treatment planning.
    Lu JE; Welch RJ; Mishra KK; Daftari IK; Park SS
    Eye (Lond); 2019 Dec; 33(12):1904-1910. PubMed ID: 31278380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton beam therapy for the treatment of uveal melanoma in Scotland.
    Macdonald EC; Cauchi P; Kemp EG
    Br J Ophthalmol; 2011 Dec; 95(12):1691-5. PubMed ID: 21216794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of high-frequency ultrasound imaging to improve delineation of anterior uveal melanoma for proton irradiation.
    Daftari I; Barash D; Lin S; O'Brien J
    Phys Med Biol; 2001 Feb; 46(2):579-90. PubMed ID: 11229735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton beam therapy and iris neovascularisation in uveal melanoma.
    Boyd SR; Gittos A; Richter M; Hungerford JL; Errington RD; Cree IA
    Eye (Lond); 2006 Jul; 20(7):832-6. PubMed ID: 16167079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plaque radiotherapy of uveal melanoma with predominant ciliary body involvement.
    Gündüz K; Shields CL; Shields JA; Cater J; Freire JE; Brady LW
    Arch Ophthalmol; 1999 Feb; 117(2):170-7. PubMed ID: 10037560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term risk of local failure after proton therapy for choroidal/ciliary body melanoma.
    Gragoudas ES; Lane AM; Munzenrider J; Egan KM; Li W
    Trans Am Ophthalmol Soc; 2002; 100():43-8; discussion 48-9. PubMed ID: 12545676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ciliary body melanomas. Survival and prognostic aspects after brachytherapy or proton therapy].
    Gambrelle J; Kodjikian L; Rouberol F; Donate D; Duquesne N; Jean-Louis B; Chauvel P; Gérard JP; Romestaing P; Grange JD
    J Fr Ophtalmol; 2004 Jan; 27(1):40-7. PubMed ID: 14968076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Plaque radiotherapy for anterior uveal melanomas].
    Saakyan SV; Amiryan AG; Valskiy VV; Mironova IS
    Vestn Oftalmol; 2015; 131(2):5-12. PubMed ID: 26080576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.